STATE STREET CORP - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$88,501,425
-30.3%
7,570,695
-19.9%
0.01%
-28.6%
Q2 2023$127,049,355
+1.6%
9,453,077
+25.3%
0.01%0.0%
Q1 2023$125,058,264
-57.3%
7,542,718
-52.1%
0.01%
-22.2%
Q4 2022$292,887,280
+202.1%
15,746,628
+108.4%
0.01%
+50.0%
Q3 2022$96,936,000
+154.3%
7,555,423
+39.0%
0.01%
+200.0%
Q2 2022$38,117,000
-0.4%
5,437,479
+17.7%
0.00%0.0%
Q1 2022$38,283,000
+12.0%
4,617,955
-8.6%
0.00%0.0%
Q4 2021$34,195,000
+6.3%
5,050,989
-16.8%
0.00%0.0%
Q3 2021$32,168,000
-6.7%
6,069,381
+1.2%
0.00%0.0%
Q2 2021$34,491,000
-16.3%
5,998,448
-32.9%
0.00%0.0%
Q1 2021$41,186,000
+101.7%
8,933,983
+46.1%
0.00%
+100.0%
Q4 2020$20,421,000
-9.9%
6,113,930
-19.9%
0.00%
-50.0%
Q3 2020$22,668,000
-26.5%
7,632,352
+14.3%
0.00%0.0%
Q2 2020$30,846,000
+7.7%
6,676,601
-10.3%
0.00%
-33.3%
Q1 2020$28,647,000
+3.0%
7,440,822
+0.3%
0.00%
+50.0%
Q4 2019$27,819,000
+44.5%
7,418,295
+104.6%
0.00%
+100.0%
Q3 2019$19,257,000
+175.4%
3,626,626
+99.1%
0.00%0.0%
Q2 2019$6,993,000
-15.7%
1,821,191
+11.9%
0.00%0.0%
Q1 2019$8,298,000
+177.8%
1,627,095
+4.6%
0.00%
Q4 2018$2,987,000
-48.3%
1,555,977
+1.9%
0.00%
Q3 2018$5,773,000
+28.6%
1,527,450
+6.2%
0.00%
Q2 2018$4,489,000
+56.1%
1,438,928
+19.5%
0.00%
Q1 2018$2,876,000
-35.4%
1,203,640
+5.8%
0.00%
Q4 2017$4,451,000
+86.9%
1,137,798
+20.5%
0.00%
Q3 2017$2,382,000
-8.0%
944,295
+0.7%
0.00%
Q2 2017$2,590,000
+2843.2%
938,195
+1971.1%
0.00%
Q1 2017$88,000
+87.2%
45,3000.0%0.00%
Q4 2016$47,000
-4.1%
45,3000.0%0.00%
Q3 2016$49,000
+48.5%
45,3000.0%0.00%
Q2 2016$33,000
-97.6%
45,300
-96.2%
0.00%
Q1 2016$1,395,000
-49.8%
1,193,974
+5.4%
0.00%
Q4 2015$2,777,000
-10.3%
1,132,629
+9.9%
0.00%
Q3 2015$3,095,000
+13.3%
1,030,431
+55.8%
0.00%
Q2 2015$2,731,000
+1315.0%
661,259
+1389.3%
0.00%
Q1 2015$193,000
+45.1%
44,4000.0%0.00%
Q4 2014$133,000
-18.9%
44,400
-10.1%
0.00%
Q3 2014$164,000
+36.7%
49,400
+4.7%
0.00%
Q2 2014$120,000
+12.1%
47,2000.0%0.00%
Q1 2014$107,000
+16.3%
47,2000.0%0.00%
Q4 2013$92,00047,2000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders